| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/JLB.65.4.458 |
| P698 | PubMed publication ID | 10204574 |
| P2093 | author name string | Alexander G | |
| Khalili K | |||
| Rappaport J | |||
| Amini S | |||
| Joseph J | |||
| Croul S | |||
| Del Valle L | |||
| P433 | issue | 4 | |
| P921 | main subject | pathology | Q7208 |
| P304 | page(s) | 458-465 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. | |
| P478 | volume | 65 |
| Q34777672 | AIDS dementia |
| Q36242243 | Adenosine receptor signaling in the brain immune system |
| Q40518676 | Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase |
| Q33808035 | Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter. |
| Q73584363 | Autoantibodies to TNFalpha in HIV-1 infection: prospects for anti-cytokine vaccine therapy |
| Q60046119 | Autophagy Induction by HIV-Tat and Methamphetamine in Primary Midbrain Neuronal Cells of Tree Shrews via the mTOR Signaling and ATG5/ATG7 Pathway |
| Q35624697 | Autophagy in dementias |
| Q40132386 | Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation |
| Q37600700 | CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. |
| Q33987022 | Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus |
| Q30885921 | Conditional Tat protein brain expression in the GT-tg bigenic mouse induces cerebral fractional anisotropy abnormalities |
| Q36728173 | Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions |
| Q33839136 | Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted |
| Q35215063 | Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury |
| Q33676138 | Crosstalk between HDAC6 and Nox2-based NADPH oxidase mediates HIV-1 Tat-induced pro-inflammatory responses in astrocytes |
| Q36764524 | Current update on HIV-associated vascular disease and endothelial dysfunction |
| Q44895700 | DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector |
| Q36296748 | Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicity |
| Q47397529 | Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model. |
| Q35000860 | Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. |
| Q36632791 | Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse |
| Q43131684 | Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes |
| Q42585205 | Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). |
| Q35022609 | Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia |
| Q33819189 | Genetic variation and HIV-associated neurologic disease. |
| Q41703176 | HDAC6 mediates HIV-1 tat-induced proinflammatory responses by regulating MAPK-NF-kappaB/AP-1 pathways in astrocytes |
| Q27023968 | HIV Associated Neurocognitive Disorders |
| Q28574361 | HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression |
| Q92548566 | HIV-1 Tat-Induced Astrocytic Extracellular Vesicle miR-7 Impairs Synaptic Architecture |
| Q35150753 | HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS |
| Q37672037 | HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. |
| Q30615171 | HIV-1-associated central nervous system dysfunction |
| Q36412589 | HIV-Tat regulates macrophage gene expression in the context of neuroAIDS. |
| Q40066321 | HIV-associated synaptic degeneration |
| Q54227299 | Hindsiipropane B alleviates HIV-1 Tat-induced inflammatory responses by suppressing HDAC6-NADPH oxidase-ROS axis in astrocytes. |
| Q36203752 | Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant? |
| Q35857699 | Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes |
| Q28182166 | Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells |
| Q36148402 | Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity |
| Q24305565 | Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein |
| Q24803889 | Infiltrative microgliosis: activation and long-distance migration of subependymal microglia following periventricular insults |
| Q83975861 | Inhibition of nuclear factor erythroid 2-related factor 2 exacerbates HIV-1 gp120-induced oxidative and inflammatory response: role in HIV associated neurocognitive disorder |
| Q26770397 | Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease |
| Q35757268 | Intra-ventral tegmental area HIV-1 Tat1-86 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic ERK and CREB signaling in rats |
| Q35317241 | Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. |
| Q36166231 | Ketone bodies protection against HIV-1 Tat-induced neurotoxicity |
| Q24301992 | MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis |
| Q28082139 | Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders |
| Q36166123 | Mechanisms of the blood-brain barrier disruption in HIV-1 infection |
| Q30437570 | Migration of perilesional microglia after focal brain injury and modulation by CC chemokine receptor 5: an in situ time-lapse confocal imaging study. |
| Q33873798 | Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDS |
| Q33753132 | Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review |
| Q24619923 | Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain |
| Q37501478 | Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport |
| Q34998247 | Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes |
| Q36302045 | Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases |
| Q33893395 | Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution |
| Q33648905 | Multi-low-dose mucosal simian immunodeficiency virus SIVmac239 challenge of cynomolgus macaques immunized with "hyperattenuated" SIV constructs |
| Q28261344 | Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions |
| Q64054571 | Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport |
| Q35749130 | Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline |
| Q44203427 | Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor |
| Q35557261 | Novel mechanisms of central nervous system damage in HIV infection. |
| Q33865700 | Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequences |
| Q35763921 | Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity. |
| Q48877809 | Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum |
| Q37366558 | PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium |
| Q34450960 | Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta. |
| Q35009483 | Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. |
| Q79869481 | Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications |
| Q36489392 | Reciprocal transactivation between HIV-1 and other human viruses |
| Q40017034 | Regulation of complement component C3 in astrocytes by IL-1beta and morphine. |
| Q38212101 | Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors |
| Q41841039 | Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. |
| Q39130522 | Tat is a multifunctional viral protein that modulates cellular gene expression and functions |
| Q38714925 | Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND. |
| Q43854537 | Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. |
| Q44010999 | The Primary Phase of Infection by Pathogenic Simian–Human Immunodeficiency Virus Results in Disruption of the Blood–Brain Barrier |
| Q26777952 | The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders |
| Q41922188 | The role of human dopamine transporter in NeuroAIDS. |
| Q34483568 | Transient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5 |
| Q44243149 | U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes |
| Q28580077 | Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands |
| Q45422129 | Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques |
| Q34356438 | beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration. |
Search more.